BioSpace News Archive

Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA) is pleased to announce a positive recommendation from the CADTH Canadian Drug Expert Committee (CDEC) for RADICAVA® Oral Suspension, the oral formulation of RADICAVA® IV (edaravone), for the treatment of patients with Amyotrophic Lateral Sclerosis (ALS).

Magstim, a global leader in neuroscience research and Transcranial Magnetic Stimulation (TMS) solutions for mental health, announced today that the FDA has cleared the Horizon 3.0 (with or without StimGuide+) and E-z Cool Coil to treat adult patients diagnosed with Obsessive Compulsive Disorder (OCD) as well as Major Depressive Disorder (MDD).

Purdue Pharma L.P. (“Purdue”) announced that FDA has accepted and granted priority review to the company’s Abbreviated New Drug Application (ANDA) for Nalmefene Hydrochloride (HCI) injection, 2 mg/2 mL (1mg/1mL) Prefilled Syringe.

RevBio, Inc., announced that it has received approval from the Italian Ministry of Health and the Ethics Committee of the University “G.D’Annunzio” of Chieti-Pescara to start a 15-patient pilot clinical trial.

Ranking Underscores Agilent’s Strong Performance on Issues of Greatest Importance to Americans Agilent Technologies Inc. is ranked 35 among the top 100 Most JUST companies, the fifth year the company has been included in the annual list by Just Capital and CNBC.

EIP Pharma Inc., a clinical stage company focused on developing treatments for neurodegenerative diseases today announced that the National Institute on Aging (NIA) of the National Institutes of Health (NIH) awarded the Company a grant of $21 million to support a 160-patient phase 2b study of neflamapimod in individuals with dementia with Lewy bodies (DLB).

Apex Labs Ltd. (APEX or the Company), a pharmaceutical company optimizing the standard of mental health care with psilocybin, is pleased to announce the commencement of patient dosing in APEX-002-A01-02 a phase 2b take home multi-dose psilocybin clinical trial approved in October of 2022 by Health Canada.

Amerimmune LLC is a translational medicine biotechnology firm focused on discovery and rapid development of novel therapies for diseases, including COVID-19.

Waters Corporation will hold its Q4 2022 financial results conference call live on Wednesday, February 15th 2023 at 8:00 a.m. eastern time.

Artificial intelligence can reconstruct coarsely-sampled, rapid magnetic resonance imaging scans into high-quality images with similar diagnostic value as those generated through traditional MRI, according to a new study by the NYU Grossman School of Medicine and Meta AI Research.